@mjanebates @LSHTM_AMR @eleanormacp Still work in progress! But our past work already points in this direction: Limitations of awareness raising: https://t.co/MxCMiwrxmy and https://t.co/b5CVzFU8Kr Role of context in AMR interventions: https://t.co/WTb7YbD
In parallel to the clinical #trial, we conducted #qualitative research to understand the implementation in the local social context. Published in Trials, we document how contextual factors influence adherence and exclusion patterns in the intervention: htt
@AnthroAMR @socscimed Brilliant initiative @AnthroAMR - our team is pushing with you! Towards #AMR-sensitive policy: https://t.co/MxCMiwrxmy Side-effects of AMR education: https://t.co/Rel4cQRNP1 Social role of diagnostic tests: https://t.co/SofB3PMZRJ Co
@DiaDev_Research Corresponds well to our research on point-of-care diagnostics to tackle #drugresistance in LMICs! - Biomarker tests have a social function that can militate against their aims: https://t.co/SofB3Q4AJh - Health system context matters for t
RT @HaenssgenJ: Antimicrobial resistance: interventions to reduce #antibiotics require tailored approach in developing countries. https://t…
RT @HaenssgenJ: Antimicrobial resistance: interventions to reduce #antibiotics require tailored approach in developing countries. https://t…
RT @HaenssgenJ: Antimicrobial resistance: interventions to reduce #antibiotics require tailored approach in developing countries. https://t…
RT @HaenssgenJ: Antimicrobial resistance: interventions to reduce #antibiotics require tailored approach in developing countries. https://t…
RT @HaenssgenJ: Antimicrobial resistance: interventions to reduce #antibiotics require tailored approach in developing countries. https://t…
RT @HaenssgenJ: Antimicrobial resistance: interventions to reduce #antibiotics require tailored approach in developing countries. https://t…
RT @HaenssgenJ: Antimicrobial resistance: interventions to reduce #antibiotics require tailored approach in developing countries. https://t…
New from #wellcometrust https://t.co/e2UvP3rXB1 How context can impact clinical trials: a multi-country qualitative case study comparison of diagnostic biomarker test interventions
Context matters also with AMR! https://t.co/ruB2gYYHr8
RT @HaenssgenJ: "Study Reveals Contextual Clues To Help Reduce Antibiotic Use" https://t.co/LSRpiocTfi @asianscientist reporting on our pap…
RT @HaenssgenJ: "Study Reveals Contextual Clues To Help Reduce Antibiotic Use" https://t.co/LSRpiocTfi @asianscientist reporting on our pap…
RT @HaenssgenJ: "Study Reveals Contextual Clues To Help Reduce Antibiotic Use" https://t.co/LSRpiocTfi @asianscientist reporting on our pap…
"Study Reveals Contextual Clues To Help Reduce Antibiotic Use" https://t.co/LSRpiocTfi @asianscientist reporting on our paper in Trials: https://t.co/QzHaxAslrz
RT @HaenssgenJ: New qualitative case study highlights impact of contextual factors on adherence and exclusion in clinical #trials - with le…
RT @HaenssgenJ: Antimicrobial resistance: interventions to reduce #antibiotics require tailored approach in developing countries. https://t…
RT @HaenssgenJ: New qualitative case study highlights impact of contextual factors on adherence and exclusion in clinical #trials - with le…
RT @HaenssgenJ: New qualitative case study highlights impact of contextual factors on adherence and exclusion in clinical #trials - with le…
RT @HaenssgenJ: Antimicrobial resistance: interventions to reduce #antibiotics require tailored approach in developing countries. https://t…
RT @HaenssgenJ: Antimicrobial resistance: interventions to reduce #antibiotics require tailored approach in developing countries. https://t…
RT @HaenssgenJ: New qualitative case study highlights impact of contextual factors on adherence and exclusion in clinical #trials - with le…
RT @HaenssgenJ: New qualitative case study highlights impact of contextual factors on adherence and exclusion in clinical #trials - with le…
RT @HaenssgenJ: Antimicrobial resistance: interventions to reduce #antibiotics require tailored approach in developing countries. https://t…
RT @HaenssgenJ: Antimicrobial resistance: interventions to reduce #antibiotics require tailored approach in developing countries. https://t…
RT @HaenssgenJ: Antimicrobial resistance: interventions to reduce #antibiotics require tailored approach in developing countries. https://t…
RT @HaenssgenJ: Antimicrobial resistance: interventions to reduce #antibiotics require tailored approach in developing countries. https://t…
RT @HaenssgenJ: Antimicrobial resistance: interventions to reduce #antibiotics require tailored approach in developing countries. https://t…
RT @HaenssgenJ: Antimicrobial resistance: interventions to reduce #antibiotics require tailored approach in developing countries. https://t…
RT @HaenssgenJ: New qualitative case study highlights impact of contextual factors on adherence and exclusion in clinical #trials - with le…
RT @HaenssgenJ: Antimicrobial resistance: interventions to reduce #antibiotics require tailored approach in developing countries. https://t…
RT @HaenssgenJ: New qualitative case study highlights impact of contextual factors on adherence and exclusion in clinical #trials - with le…
RT @HaenssgenJ: New qualitative case study highlights impact of contextual factors on adherence and exclusion in clinical #trials - with le…
RT @HaenssgenJ: Antimicrobial resistance: interventions to reduce #antibiotics require tailored approach in developing countries. https://t…
RT @HaenssgenJ: Antimicrobial resistance: interventions to reduce #antibiotics require tailored approach in developing countries. https://t…
RT @HaenssgenJ: Antimicrobial resistance: interventions to reduce #antibiotics require tailored approach in developing countries. https://t…
RT @HaenssgenJ: Antimicrobial resistance: interventions to reduce #antibiotics require tailored approach in developing countries. https://t…
Now on @GrowKudos: The outcomes of your clinical trial depend on where you implement it https://t.co/t6LVeo7Jep
RT @HaenssgenJ: Antimicrobial resistance: interventions to reduce #antibiotics require tailored approach in developing countries. https://t…
Perhaps of interest for @CDDEP @Wellcome_AMR @longitude_prize @LSHTM_AMR @Marcsprenger4PH @HPRUamr @Wellcome_AMR?
Our study is featured on @WarwickGSD news! News: https://t.co/2EQoUFgGVc Article: https://t.co/QzHaxAslrz
RT @HaenssgenJ: Antimicrobial resistance: interventions to reduce #antibiotics require tailored approach in developing countries. https://t…
RT @HaenssgenJ: Antimicrobial resistance: interventions to reduce #antibiotics require tailored approach in developing countries. https://t…
RT @HaenssgenJ: Antimicrobial resistance: interventions to reduce #antibiotics require tailored approach in developing countries. https://t…
RT @HaenssgenJ: Antimicrobial resistance: interventions to reduce #antibiotics require tailored approach in developing countries. https://t…
RT @HaenssgenJ: Antimicrobial resistance: interventions to reduce #antibiotics require tailored approach in developing countries. https://t…
RT @HaenssgenJ: Antimicrobial resistance: interventions to reduce #antibiotics require tailored approach in developing countries. https://t…
RT @HaenssgenJ: Antimicrobial resistance: interventions to reduce #antibiotics require tailored approach in developing countries. https://t…
RT @HaenssgenJ: Antimicrobial resistance: interventions to reduce #antibiotics require tailored approach in developing countries. https://t…
RT @HaenssgenJ: Antimicrobial resistance: interventions to reduce #antibiotics require tailored approach in developing countries. https://t…
Antimicrobial resistance: interventions to reduce #antibiotics require tailored approach in developing countries. https://t.co/fsTWpAvUfW @warwickuni @warwicknewsroom featuring our research on the context of clinical trials in Southeast Asia. Read more at:
RT @HaenssgenJ: New qualitative case study highlights impact of contextual factors on adherence and exclusion in clinical #trials - with le…
RT @HaenssgenJ: New qualitative case study highlights impact of contextual factors on adherence and exclusion in clinical #trials - with le…
RT @HaenssgenJ: New qualitative case study highlights impact of contextual factors on adherence and exclusion in clinical #trials - with le…
RT @HaenssgenJ: New qualitative case study highlights impact of contextual factors on adherence and exclusion in clinical #trials - with le…
How context can impact clinical trials: a multi-country qualitative case study comparison of diagnostic biomarker test interventions. https://t.co/ugLQjc2bhV
RT @HaenssgenJ: New qualitative case study highlights impact of contextual factors on adherence and exclusion in clinical #trials - with le…
RT @HaenssgenJ: New qualitative case study highlights impact of contextual factors on adherence and exclusion in clinical #trials - with le…
RT @HaenssgenJ: New qualitative case study highlights impact of contextual factors on adherence and exclusion in clinical #trials - with le…
RT @HaenssgenJ: New qualitative case study highlights impact of contextual factors on adherence and exclusion in clinical #trials - with le…
RT @HaenssgenJ: New qualitative case study highlights impact of contextual factors on adherence and exclusion in clinical #trials - with le…
RT @HaenssgenJ: New qualitative case study highlights impact of contextual factors on adherence and exclusion in clinical #trials - with le…
RT @HaenssgenJ: New qualitative case study highlights impact of contextual factors on adherence and exclusion in clinical #trials - with le…
RT @HaenssgenJ: New qualitative case study highlights impact of contextual factors on adherence and exclusion in clinical #trials - with le…
...and in case the doi link doesn't work: https://t.co/WTb7YbD72Q
New qualitative case study highlights impact of contextual factors on adherence and exclusion in clinical #trials - with lessons for #AMR #biomarker tests. Published today in Trials journal! https://t.co/QzHaxAslrz @_ErnErnErn_ @YuzanaKhineZaw @Y_Lubell @H